The leading knowledge platform for the financial technology industry
The leading knowledge platform for the financial technology industry

A-Team Insight Blogs

CFTC and SEC Divvy up Derivatives Pie, CME’s Donohue Expresses Concern About Illiquid Derivatives

Following a brief hiatus, the turf war is back on between the Securities and Exchange Commission (SEC) and the Commodity Futures Trading Commission (CFTC). Just how the two regulators will divide up the oversight of the derivatives market is currently being debated across the industry and could have wide ramifications for those involved in the sector.

SEC chairman Mary Schapiro is keen to get more authority over more OTC products including securities related swaps, and has been vigorously lobbying Congress over the last week to that end. “Primary responsibility for securities related OTC derivatives would be retained by the SEC, which is also responsible for oversight of markets affected by this subset of OTC derivatives,” Schapiro said in testimony before the Senate Banking Subcommittee on Securities earlier this week.

She contended that oversight of foreign exchange, interest rate and commodity swaps should be the remit of the CFTC, while the Fed should oversee systemically important banks that are involved in the derivatives business. Schapiro stressed that firms should not be subject to duplicative oversight processes: “OTC derivatives dealers that are banks would be subject to prudential supervision by their federal banking regulator. All other OTC derivatives dealers in securities related OTC derivatives would be subject to supervision and regulation by the SEC.”

This is a rather difficult proposition given the circumstances and it also sustains the current confusing patchwork of regulatory oversight in the country. Turf battles are likely to reoccur in the future as regulators are forced to negotiate which financial institutions fall under their remit. The likely impact on these firms is the imposition of more onerous reporting requirements by regulators seeking to prove their competence. Duplicative reporting processes may also be maintained and this could have a significant impact on their compliance, record keeping and reporting systems.

The plans will also require all standardised OTC products to go through clearing houses in order to reduce counterparty risk in the market. Moreover these products will also be required to be traded by electronic execution methods, whereas more complex OTC derivatives will be subject to new mandatory reporting requirements. This data on complex products would then be stored in a trade repository for regulatory reference purposes.

The plan for clearing OTC derivatives has stirred up some controversy in the market already. For example, this week, Craig Donohue, chief executive of CME Group, indicated that he believes it would be dangerous for all these products to be forced into being cleared electronically. “We have to be careful to manage the risk profile of what we clear and there will be a range of things that we would not be comfortable clearing,” he warned.

Donohue is keen for the market to have some sway in deciding what is centrally cleared, rather than being forced to clear all standardised trades. “We want to be able to make the decision to clear what we feel comfortable with from a risk perspective,” he said.

These concerns are warranted and, given the focus on systemic risk, are likely to be seconded by a number of other participants in the market. However, much like deciding how big each regulator’s share of the derivatives pie will be, it will be up to the powers that be to decide whether these warnings are heeded.

Related content

WEBINAR

Upcoming Webinar: Unifying client data to accelerate insights and deliver better experiences

Date: 30 June 2021 Time: 10:00am ET / 3:00pm London / 4:00pm CET Duration: 50 minutes Data insight is critical to all aspects of the buy-side investment process from portfolio decisions that drive core revenue and incremental revenue opportunities, to delivering unique and timely investment research, and rapidly innovating and offering new products to clients....

BLOG

Post-Brexit UK Sanctions Regime Adds Complexity as Firms Wrestle with Global Compliance

The post-Brexit UK sanctions regime has added complexity to firms’ efforts to comply with international sanctions regimes, in some cases changing their appetite for risk, according to a recent A-Team webinar on the topic. And although much of the UK regime has been transposed from EU regulation, small but significant changes are adding to the...

EVENT

Data Management Summit USA Virtual

Now in its 11th year, the Data Management Summit USA Virtual explores the shift to the new world where data is redefining the operating model and firms are seeking to unlock value via data transformation projects for enterprise gain and competitive edge.

GUIDE

Entity Data Management Handbook – Seventh Edition

Sourcing entity data and ensuring efficient and effective entity data management is a challenge for many financial institutions as volumes of data rise, more regulations require entity data in reporting, and the fight again financial crime is escalated by bad actors using increasingly sophisticated techniques to attack processes and systems. That said, based on best...